Effects of acute and repeated clozapine injections on cholinomimetic-induced vacuous jaw movements

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 3, 1996, Pages 619-624

  Chesler, Elissa J ^a   Salamone, John D ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Acetylcholine; Atypical neuroleptic; Dopamine; Parkinson's disease; Purposeless chewing; Serotonin; Tremor; Vacuous chewing

Indexed keywords

ANIMALIA; PARKINSONIA;

CLOZAPINE; NEUROLEPTIC AGENT; PHYSOSTIGMINE; PILOCARPINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; JAW MOVEMENT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; HYPNOTICS AND SEDATIVES; MALE; PARASYMPATHOMIMETICS; PHYSOSTIGMINE; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029952330     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02280-5     Document Type: Article

References (52)

1. Adams, R. D.; Victor, M. Tremors, myoclonus, spasms, and tics. Principles of neurology. New York: McGraw-Hill; 1981:69-77.
2. Agid, Y.; Guyenet, P.; Glowinski, J.; Beaujouan, J. C.; Javoy, F. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons of the rat. Brain Res. 86:488-492; 1975.
3. Arevalo, G. J.; Gershanik, O. S. Modulatory effect of clozapine on levodopa response in Parkinson's disease: A preliminary study. Movement Disord. 8:349-354; 1993.
4. Baskin, P.; Salamone, J. D. Vacuous jaw movements in rats induced by acute reserpine administration: Interactions with different doses of apomorphine. Pharmacol. Biochem. Behav. 46: 793-797; 1993.
5. Baskin, P.; Gianutsos, G.; Salamone, J. D. Repeated scopolamine injections sensitize rats to pilocarpine-induced vacuous jaw movements and enhance striatal muscarinic receptor binding. Pharmacol. Biochem. Behav. 49:437-442; 1994.
6. Bernardi, F.; Del Zompo, M. Clozapine in idiopathic Parkinson's disease. Neurol. 40:1151; 1990.
7. Burke, M.; Sebastian, C. Treatment of clozapine sedation. Am. J. Psychiatry 150:1900-1901; 1993.
8. Casey, D. E. Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates. Psychopharmacology (Berlin) 112:555-859; 1993.
9. Duvoisin, R. C. Cholinergic-anticholinergic antagonism in parkinsonism. Arch. Neurol. 17:124-136; 1967.
10. Ellison, G.; See, R. Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia. Psychopharmacology (Berlin) 98: 564-566; 1989.
11. Friedman, J. H.; Lannon, M. C. Clozapine-responsive tremor in Parkinson's disease. Movement Disord. 5:225-229; 1990.
12. Glassman, R. B.; Glassman, H. N. Oral dyskinesia in brain-damaged rats withdrawn from neuroleptic: Implication for models of tardive dyskinesia. Psychopharmacology (Berlin) 69:19-25; 1980.
13. Gunne, L. M.; Growden, J.; Glaeser, B. Oral dyskinesia in rats following brain lesions and neuroleptic administration. Psychopharmacology (Berlin) 77:134-139; 1982.
14. Gunne, L. M.; Andersson, U.; Bondesson, U.; Johansson, P. Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol. Biochem. Behav. 25:897-901; 1986.
15. Harbaugh, R. E.; Roberts, D. W.; Coombs, D. W.; Saunders, R. L.; Reeder, T. M. Preliminary report: Intracranial cholinergic drug infusion in patients with Alzheimer's disease. Neurosurgery 15:514-518; 1984.
16. Hirsch, E.; Auff, E.; Birkmayer, W.; Schnaberth, G.; Riederer, P. Ritanserin in the treatment of Parkinson's disease. In: Nappi, G.; Caraceni, T., eds. Parkinsonism: Diagnosis and treatment. New York: Laurel House; 1989:199-203.
17. Hunker, C. J.; Abbs, J. H. Uniform frequency of Parkinsonian resting tremor in the lips, jaw, tongue, and index finger. Movement Disord. 5:71-77; 1990.
18. Jicha, G.; Salamone, J. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: Possible relation to Parkinsonian symptoms. J. Neurosci. 11: 3822-3829; 1991.
19. Johansson, P.; Casey, D. E.; Gunne, L. M. Dose-dependent increases in rat spontaneous chewing rates during long-term administration of haloperidol but not clozapine. Psychopharmacol. Bull. 22:1017-1019; 1986.
20. Kelley, A. E.; Bakshi, V. P.; Delfs, J. M.; Lang, C. G. Cholinergic stimulation of the ventrolateral striatum elicits mouth movements in rats: Pharmacological and regional specificity. Psychopharmacology (Berlin) 99:542-549; 1989.
21. Koek, W.; Colpaert, F. C. Inhibition of methylphenidate-induced behaviors in rats: Differences among neuroleptics. J. Pharmacol. Exp.Ther. 267:181-191; 1993.
22. Kostrzewa, R. M.; Brus, R.; Perry, K. W.; Fuller, R. W. Age-dependence of a 6-hydroxydopamine lesion on SKF 38393 and m-chlorophenylpiperazine-induced oral activity responses of rats. Brain Res. 76:87-93; 1993.
23. 2 dopamine receptor interactions with pilocarpine-induced oral activity in rats. Pharmacol. Biochem. Behav. 33:501-505; 1989.
24. Lieberman, J.; Kane, J.; Johns, C. Clozapine: Guidelines for clinical management. J. Clin. Psychiatry 50:329-338; 1989.
25. Lindstrom, L. H. The effect of long term treatment of clozapine in schizophrenia: A retrospective study of 96 patients treated with clozapine for up to 13 years. Acta. Psychiatr. Scand. 77:524-529; 1988.
26. Marsden, C. D.; Tarsy, D. Baldessarini, R. J. Spontaneous and drug-induced movement disorders in psychotic patients. In: Bendon, D. F.; Blumer, D., eds. Psychiatric aspects of neurological disease. New York: Grune and Stratten; 1975:219-266.
27. 2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J. Pharmacol. Exp. Ther. 266:498-508; 1993.
28. McEvoy, J. P. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. J. Clin. Psychopharmacol. 3:288-301; 1983.
29. Meltzer, H. Y. Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berlin) 99:s18-s27; 1989.
30. Neisewander, J. L.; Lucki, I.; McGonigle, P. Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment. Brain Res. 558:27-35; 1991.
31. Noring, U.; Povlesen, U. J.; Casey, D. E.; Gerlach, J. Effect of a cholinomimetic drug (RS 86) in tardive dyskinesia and drug-related Parkinsonism. Psycholpharmacology (Berlin) 84:569-571; 1984.
32. Pakkenberg, H.; Pakkenberg, B. Clozapine in the treatment of tremor. Acta Neurol. Scand. 73:295-297; 1986.
33. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Cholinergic modulation of perioral behavior induced by chronic neuroleptic administration to rats. Psychpharmacology (Berlin) 79:226-230; 1983.
34. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Pharmacological characterization of spontaneous or drug-induced purposeless chewing movements in rats. Psychopharmacology (Berlin) 85:71-79; 1985.
35. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berlin) 88: 403-419; 1986.
36. Safferman, A.; Lieberman, J. A.; Kane, J. M.; Szymanski, S.; Kinon, B. Update on the clinical efficacy of clozapine. Schizophr. Bull. 17:247-261; 1991.
37. Salamone, J. D.; Baskin, P. B. Vacuous jaw movements induced by reserpine and low-dose apomorphine: Possible model of Parkinsonian tremor. Pharmacol. Biochem. Behav. 53:179-183; 1996.
38. Salamone, J. D.; Cousins, M. S.; Maio, C.; Champion, M.; Turski, T.; Kovach, J. Different behavioral effects of haloperidol, clozapine and thioridazine in an instrumental lever pressing/feeding procedure. Psychopharmacology (Berlin) (in press).
39. Salamone, J. D.; Lalies, M. D.; Channell, S. L.; Iversen, S. D. Behavioral and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat. Psychopharmacology (Berlin) 88:467-471; 1986.
40. Salamone, J. D.; Johnson, C. J.; McCullough, L. D.; Steinpreis, R. E. Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat. Psychopharmacology (Berlin) 102:529-534; 1990.
41. Schmauss, M.; Wolff, R.; Erfurth, A.; Ruther, E. Tolerability of long term clozapine treatment. Psychopharmacology (Berlin) 99: s105-s108; 1989.
42. Snyder, S. H.; Banerjee, S. P; Yamamura, H. I.; Greenberg, D. Drugs, neurotransmitters and schizophrenia. Science 184:1243-1253; 1974.
43. Steinpreis, R. E.; Baskin, P. P.; Salamone, J. D. Vacuous jaw movements induced by subchronic administration of haloperidol: Interactions with scopolamine. Psychopharmacology (Berlin) 111: 99-105; 1993.
44. Steinpreis, R. E.; Salamone, J. D. The effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats. Pharmacol. Biochem. Behav. 46:405-409; 1993.
45. Stewart, B. R.; Jenner, P.; Marsden, C. D. The pharmacological characterization of pilocarpine-induced chewing in the rat. Psychopharmacology (Berlin) 97:228-234; 1988.
46. Stewart, B. R.; Jenner, P.; Marsden, C. D. Induction of purposeless chewing behaviour in rats by 5-HT agonist drugs. Eur. J. Pharmacol. 162:101-107; 1989.
47. Stewart, B. R.; Rose, S.; Jenner, P.; Marsden, C. D. Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HT. Eur. J. Pharmacol. 142:173-176; 1987.
48. Stoessl, A. J.; Martin-Iversen, M. T.; Barth, T. M.; Dourish, C. T.; Iversen, S. D. Effects of ageing on the behavioural responses to dopaminergic agonists: Decreased yawning and locomotion, but increased stereotypy. Brain Res. 495:20-30; 1989.
49. Tarsy, D. Neuroleptic-induced extrapyramidal reactions: Classification, description and diagnosis. Clin. Neuropsychopharmacol. 6:s9-s26; 1983.
50. Van Putten, T.; Wirshing, W. C.; Marder, S. R. Tardive Meige syndrome responsive to clozapine. J. Clin. Psychopharmacol. 10: 381-382; 1990.
51. Waddington, J. L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology (Berlin) 101:431-447; 1990.
52. Wiley, J. L.; Compton, A. D.; Porter, J. H. Differential effects of clozapine and pimozide on fixed-ratio responding during repeated dosing. Pharmacol. Biochem. Behav. 48:253-257; 1994.